Food. Science. Momentum.In the emerging world of applied science, Whitewave Food (NYSE: WWAV), a spinoff from Dean Foods is prototypical of an emerging sector, that of applied science without the emphasis on electronic products such as phones and PCs. The company harnesses the power of nature with its focus on… Read More
Archive
Filter
Food. Science. Momentum.In the emerging world of applied science, Whitewave Food (NYSE: WWAV), a spinoff from Dean Foods is prototypical of an emerging sector, that of applied science without the emphasis on electronic products such as phones and PCs. The company harnesses the power of nature with its focus on… Read More
The cloud megatrend is a significant positive force for Arista Networks (ANET), a pure-play high-speed datacenter switch vendor with a focus on software. Founded in 2004, the company shipped its first product in 2008. Since then, it has become a major disruptor in the switching market. I am adding Arista… Read More
The cloud megatrend is a significant positive force for Arista Networks (ANET), a pure-play high-speed datacenter switch vendor with a focus on software. Founded in 2004, the company shipped its first product in 2008. Since then, it has become a major disruptor in the switching market. I am adding Arista… Read More
Our foray into UBIO, the leveraged long biotech ETF, got a rough start. But those investors who have owned BIS, the inverse leveraged biotech ETF, especially simultaneously with UBIO have fared better overall since BIS shares have risen during the period in which UBIO has fallen. We still think that biotech… Read More
Our foray into UBIO, the leveraged long biotech ETF, got a rough start. But those investors who have owned BIS, the inverse leveraged biotech ETF, especially simultaneously with UBIO have fared better overall since BIS shares have risen during the period in which UBIO has fallen. We still think that biotech… Read More
Buy ProShares UltraPro Nasdaq Biotech ETF (UBIO) up to $27, with a stop loss at $23. Read More
Buy ProShares UltraPro Nasdaq Biotech ETF (UBIO) up to $27, with a stop loss at $23. Read More
Long time subscribers to Smart Tech Investor may recall our story from last June on exoskeleton technology (“From Comic Books to Reality: Exoskeletons Are Here to Stay“), which recommended three companies that are currently held in our Special Situations Portfolio: Ekso Bionics (EKSO), ReWalk Robotics (RWLK) and Parker Hannifin (PH). Read More
I am upgrading FireEye to a ‘Buy’ from ‘Hold’ in the Next Wave Portfolio because of the company’s new focus on security subscriptions. Read More